Patients in the COVID group generally had lower signs of inflammation (CRP 12.2 mg/L), which is consistent with the majority of published data [7,19,22] which also applies to the incidence of pneumonia and pleural effusions in the COVID group [4,15,18,22]. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.